Cancer in People with HIV
- PMID: 39111924
- PMCID: PMC11529824
- DOI: 10.1016/j.idc.2024.06.007
Cancer in People with HIV
Abstract
We review the intersection of human immunodeficiency virus (HIV) and cancer globally, including the complex interplay of oncogenic infections, chronic inflammation, and behavioral and other factors in increasing cancer risk among people with HIV (PWH). We discuss current cancer screening, prevention, and treatment recommendations for PWH. Specific interventions include vaccination, behavioral risk reduction, timely HIV diagnosis and treatment, screening for specific cancer sites, and multifaceted treatment considerations unique to PWH including supportive care and drug interactions. Finally, the potential of novel therapies and the need for inclusive cancer clinical trials are highlighted. Collaborative multidisciplinary efforts are critical for continued progress against cancer among PWH.
Keywords: Acquired immunodeficiency disease defining cancers; Cancer in people with human immunodeficiency virus; Human immunodeficiency virus malignancies; Human immunodeficiency virus-associated cancers.
Published by Elsevier Inc.
Conflict of interest statement
Disclosure T.A. Odeny received grant funding from Gilead Sciences. V. Fink participated as speaker and expert discussant for MSD. The opinions expressed in this article are the authors own and do not reflect the view of the NIH, the Department of Health and Human Services, or the United States Government.
Figures
References
-
- Key Populations - Eswatini National AIDS Program. Dec 2023, 2023. http://swaziaidsprogram.org/key-populations/
-
- Simbayi L, Zuma K, Zungu N, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017: towards achieving the UNAIDS 90–90-90 targets. 2019;
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical